Abstract
APOBEC3 protein families, a DNA cytidine deaminase, were up-regulated in multiple tumors. However, the relationship between Hepatocellular carcinoma (HCC) and APOBEC3B (A3B) remains unknown. It has been confirmed that interleukin-6 (IL-6) has significant impacts on oncogenesis of HCC. Here, we reported that the expression of IL-6 was substantially up-regulated by A3B in HepG2 cells. A3B induced IL-6 expression through relocating HuR to enhance the IL-6 mRNA stability. Further analysis indicated that IL-6 also increased the expression of A3B through JAK1/STAT3 signaling pathway, which formed a positive feedback to maintain the continuous expression of A3B and IL-6, and thereby promoted the prolonged non-resolving inflammation. Collectively, these findings suggest that A3B is essential for oncogenesis of HCC, and is a potential target for preventive intervention.
Similar content being viewed by others
References
Beck, B., and Blanpain, C. (2013). Unravelling cancer stem cell potential. Nat Rev Cancer 13, 727–738.
Bishop, K.N., Holmes, R.K., Sheehy, A.M., Davidson, N.O., Cho, S.J., and Malim, M.H. (2004). Cytidine deamination of retroviral DNA by diverse APOBEC proteins. Curr Biol 14, 1392–1396.
Bonvin, M., Achermann, F., Greeve, I., Stroka, D., Keogh, A., Inderbitzin, D., Candinas, D., Sommer, P., Wain-Hobson, S., Vartanian, J.P., and Greeve, J. (2006). Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication. Hepatology 43, 1364–1374.
Burns, M.B., Lackey, L., Carpenter, M.A., Rathore, A., Land, A.M., Leonard, B., Refsland, E.W., Kotandeniya, D., Tretyakova, N., Nikas, J.B., Yee, D., Temiz, N.A., Donohue, D.E., McDougle, R.M., Brown, W.L., Law, E.K., and Harris, R.S. (2013a). APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494, 366–370.
Burns, M.B., Temiz, N.A., and Harris, R.S. (2013b). Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat Genet 45, 977–983.
Chang, P.E., Ong, W.C., Lui, H.F., and Tan, C.K. (2013). Epidemiology and prognosis of paraneoplastic syndromes in hepatocellular carcinoma. ISRN Oncol 2013, 684026.
Chisari, F.V., Klopchin, K., Moriyama, T., Pasquinelli, C., Dunsford, H.A., Sell, S., Pinkert, C.A., Brinster, R.L., and Palmiter, R.D. (1989). Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59, 1145–1156.
Dubois-Pot-Schneider, H., Fekir, K., Coulouarn, C., Glaise, D., Aninat, C., Jarnouen, K., Le Guével, R., Kubo, T., Ishida, S., Morel, F., and Corlu, A. (2014). Inflammatory cytokines promote the retrodifferentiation of tumor-derived hepatocyte-like cells to progenitor cells. Hepatology 60, 2077–2090.
Edwards, B.K., Noone, A.M., Mariotto, A.B., Simard, E.P., Boscoe, F.P., Henley, S.J., Jemal, A., Cho, H., Anderson, R.N., Kohler, B.A., Eheman, C.R., and Ward, E.M. (2014). Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 120, 1290–1314.
He, G., Dhar, D., Nakagawa, H., Font-Burgada, J., Ogata, H., Jiang, Y., Shalapour, S., Seki, E., Yost, S.E., Jepsen, K., Frazer, K.A., Harismendy, O., Hatziapostolou, M., Iliopoulos, D., Suetsugu, A., Hoffman, R.M., Tateishi, R., Koike, K., and Karin, M. (2013). Identification of liver cancer progenitors whose malignant progression depends on autocrine IL-6 signaling. Cell 155, 384–396.
He, G., Yu, G.Y., Temkin, V., Ogata, H., Kuntzen, C., Sakurai, T., Sieghart, W., Peck-Radosavljevic, M., Leffert, H.L., and Karin, M. (2010). Hepatocyte IKKß/NF-?B inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell 17, 286–297.
Henderson, S., Chakravarthy, A., Su, X., Boshoff, C., and Fenton, T.R. (2014). APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development. Cell Rep 7, 1833–1841.
Hunter, C.A., and Jones, S.A. (2015). IL-6 as a keystone cytokine in health and disease. Nat Immunol 16, 448–457.
Jemal, A., Bray, F., Center, M.M., Ferlay, J., Ward, E., and Forman, D. (2011). Global cancer statistics. CA Cancer J Clin 61, 69–90.
Johnson, C., Han, Y., Hughart, N., McCarra, J., Alpini, G., and Meng, F. (2012). Interleukin-6 and its receptor, key players in hepatobiliary inflammation and cancer. Transl Gastrointest Cancer 1, 58–70.
Köck, J., and Blum, H.E. (2008). Hypermutation of hepatitis B virus genomes by APOBEC3G, APOBEC3C and APOBEC3H. J General Virology 89, 1184–1191.
Koning, F.A., Newman, E.N.C., Kim, E.Y., Kunstman, K.J., Wolinsky, S.M., and Malim, M.H. (2009). Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets. J Virology 83, 9474–9485.
Lackey, L., Demorest, Z.L., Land, A.M., Hultquist, J.F., Brown, W.L., and Harris, R.S. (2012). APOBEC3B and AID have similar nuclear import mechanisms. J Mol Biol 419, 301–314.
Leonard, B., Hart, S.N., Burns, M.B., Carpenter, M.A., Temiz, N.A., Rathore, A., Vogel, R.I., Nikas, J.B., Law, E.K., Brown, W.L., Li, Y., Zhang, Y., Maurer, M.J., Oberg, A.L., Cunningham, J.M., Shridhar, V., Bell, D.A., April, C., Bentley, D., Bibikova, M., Cheetham, R.K., Fan, J.B., Grocock, R., Humphray, S., Kingsbury, Z., Peden, J., Chien, J., Swisher, E.M., Hartmann, L.C., Kalli, K.R., Goode, E.L., Sicotte, H., Kaufmann, S.H., and Harris, R.S. (2013). APOBEC3B upregulation and genomic mutation patterns in serous ovarian carcinoma. Cancer Res 73, 7222–7231.
Liu, F., Zhang, W., Yang, F., Feng, T., Zhou, M., Yu, Y., Yu, X., Zhao, W., Yi, F., Tang, W., and Lu, Y. (2016). Interleukin-6-stimulated progranulin expression contributes to the malignancy of hepatocellular carcinoma cells by activating mTOR signaling. Sci Rep 6, 21260.
Mantovani, A., Allavena, P., Sica, A., and Balkwill, F. (2008). Cancer-related inflammation. Nature 454, 436–444.
Mantovani, A., Garlanda, C., and Allavena, P. (2010). Molecular pathways and targets in cancer-related inflammation. Ann Med 42, 161–170.
McMullen, M.R., Cocuzzi, E., Hatzoglou, M., and Nagy, L.E. (2003). Chronic ethanol exposure increases the binding of HuR to the TNFa 3’-untranslated region in macrophages. J Biol Chem 278, 38333–38341.
Mehta, H.V., Jones, P.H., Weiss, J.P., and Okeoma, C.M. (2012). IFN-a and lipopolysaccharide upregulate APOBEC3 mRNA through different signaling pathways. J Immunol 189, 4088–4103.
Nathan, C., and Ding, A. (2010). Nonresolving inflammation. Cell 140, 871–882.
Okeoma, C.M., Huegel, A.L., Lingappa, J., Feldman, M.D., and Ross, S.R. (2010). APOBEC3 proteins expressed in mammary epithelial cells are packaged into retroviruses and can restrict transmission of milk-borne virions. Cell Host Microbe 8, 534–543.
Okeoma, C.M., Lovsin, N., Peterlin, B.M., and Ross, S.R. (2007). APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 445, 927–930.
Peng, G., Lei, K.J., Jin, W., Greenwell-Wild, T., and Wahl, S.M. (2006). Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti–HIV-1 activity. J Exp Med 203, 41–46.
Shinohara, M., Io, K., Shindo, K., Matsui, M., Sakamoto, T., Tada, K., Kobayashi, M., Kadowaki, N., and Takaori-Kondo, A. (2012). APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells. Sci Rep 2, 806.
Suzuki, E., Tsutsumi, A., Sugihara, M., Mamura, M., Goto, D., Matsumoto, I., Ito, S., Ikeda, K., Ochiai, N., Sato, Y., and Sumida, T. (2006). Expression of TNF-alpha, tristetraprolin, T-cell intracellular antigen-1 and Hu antigen R genes in synovium of patients with rheumatoid arthritis. Int J Mol Med 18, 273–278.
Tanaka, Y., Marusawa, H., Seno, H., Matsumoto, Y., Ueda, Y., Kodama, Y., Endo, Y., Yamauchi, J., Matsumoto, T., Takaori-Kondo, A., Ikai, I., and Chiba, T. (2006). Anti-viral protein APOBEC3G is induced by interferon-a stimulation in human hepatocytes. Biochem Biophysical Res Commun 341, 314–319.
Turelli, P., Liagre-Quazzola, A., Mangeat, B., Verp, S., Jost, S., and Trono, D. (2008). APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice. J Virology 82, 6585–6590.
Vartanian, J.P., Henry, M., Marchio, A., Suspène, R., Aynaud, M.M., Gué tard, D., Cervantes-Gonzalez, M., Battiston, C., Mazzaferro, V., Pineau, P., Dejean, A., and Wain-Hobson, S. (2010). Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis. PLoS Pathog 6, e1000928.
Wan, S., Zhao, E., Kryczek, I., Vatan, L., Sadovskaya, A., Ludema, G., Simeone, D.M., Zou, W., and Welling, T.H. (2014). Tumor-associated macrophages produce interleukin 6 and signal via STAT3 to promote expansion of human hepatocellular carcinoma stem cells. Gastroenterology 147, 1393–1404.
Wang, H., Su, X., Yang, M., Chen, T., Hou, J., Li, N., and Cao, X. (2015). Reciprocal control of miR-197 and IL-6/STAT3 pathway reveals miR-197 as potential therapeutic target for hepatocellular carcinoma. OncoImmunology 4, e1031440.
Wang, W., Caldwell, M.C., Lin, S., Furneaux, H., and Gorospe, M. (2000). HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation.
EMBO J 19, 2340–2350.
Williams, G.M., Iatropoulos, M.J., and Jeffrey, A.M. (2000). Mechanistic basis for nonlinearities and thresholds in rat liver carcinogenesis by the DNA-reactive carcinogens 2-acetylaminofluorene and diethylnitrosamine. Toxicologic Pathol 28, 388–395.
Xu, R., Zhang, X., Zhang, W., Fang, Y., Zheng, S., and Yu, X.F. (2007). Association of human APOBEC3 cytidine deaminases with the generation of hepatitis virus B x antigen mutants and hepatocellular carcinoma. Hepatology 46, 1810–1820.
Yang, X., Wang, W., Fan, J., Lal, A., Yang, D., Cheng, H., and Gorospe, M. (2004). Prostaglandin A2-mediated Stabilization of p21 mRNA through an ERK-dependent Pathway Requiring the RNA-binding Protein HuR. J Biol Chem 279, 49298–49306.
Ying, S., Zhang, X., Sarkis, P.T.N., Xu, R., and Yu, X. (2007). Cell-specific regulation of APOBEC3F by interferons. Acta Biochim Biophys Sin 39, 297–304.
Zhou, H., Jarujaron, S., Gurley, E.C., Chen, L., Ding, H., Studer, E., Pandak Jr., W.M., Hu, W., Zou, T., Wang, J.Y., and Hylemon, P.B. (2007). HIV protease inhibitors increase TNF-α and IL-6 expression in macrophages: Involvement of the RNA-binding protein HuR. Atherosclerosis 195, e134–e143
Acknowledgements
This work was supported in part by the National Natural Science Foundation of China (91529304, 81502407, 81473230, 81273547, 81403020 and 91129731), the Jiangsu Province Natural Science Foundation of China (BK2014666), and the Central College Fund (ZJ14020).
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Li, S., Bao, X., Wang, D. et al. APOBEC3B and IL-6 form a positive feedback loop in hepatocellular carcinoma cells. Sci. China Life Sci. 60, 617–626 (2017). https://doi.org/10.1007/s11427-016-9058-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-016-9058-6